This is a routine vesting disclosure with no trading signal. Monitor for any subsequent open-market sales by Soriot, which would be separately reported. No immediate action warranted.
Price Chart
Executive Summary
AstraZeneca filed a 6-K reporting the vesting of a performance share award to CEO Pascal Soriot on 14 May 2026. The award, granted in 2021 under the AstraZeneca Performance Share Plan, vested at 88% of target after a three-year performance period and two-year holding period, with 18,359 shares acquired for nil consideration. This is a routine executive compensation disclosure with no material financial or operational impact.
Key Facts
- CEO Pascal Soriot received 18,359 ordinary shares upon vesting of a 2021 AZPSP award on 14 May 2026.
- The award vested at 88% of target after a three-year performance period and two-year holding period.
- Shares were acquired for nil consideration; 13,766 pence per share was the fair market value for tax purposes.
- The filing is a routine PDMR shareholding disclosure with no new business or financial information.
Financial Impact
No material financial impact. The vesting involves 18,359 shares at a tax reference value of 13,766 pence each, but no cash consideration changed hands.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-005049 |
| Document: 0001654954-26-005049-index-headers.html | 0001654954-26-005049 |
| Document: 0001654954-26-005049-index.html | 0001654954-26-005049 |
| Document: 0001654954-26-005049.txt | 0001654954-26-005049 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 6-K | $161.85 $168.37 | ▲ +4.03% | ▲ +1.90% | $157.02 (−2.98%) |
Sep 14, 2026 18d ago | 6-K | $163.78 $168.10 | ▼ −2.64% | ▼ −2.53% | $157.02 (+4.13%) |
Sep 8, 2026 24d ago | 6-K | $160.04 $161.85 | ▲ +1.13% | ▲ +2.25% | $157.02 (−1.89%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.22 $156.94 | ▼ −3.25% | ▼ −3.33% | $157.02 (−3.20%) |
Sep 1, 2026 4w ago | 6-K | $162.47 $156.94 | ▼ −3.40% | ▼ −3.49% | $157.02 (−3.35%) |
Aug 31, 2026 4w ago | Court Ruling | $162.13 $159.95 | ▲ +1.34% | ▲ +1.20% | $157.02 (+3.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access